Table 2.
Correlations of SLAM in SLE patients
| Correlations | r value | p value |
|---|---|---|
| SLAM versus lymphocytes % BALF | 0.54 | 0.001 |
| SLAM versus macrophages % BALF | –0.52 | 0.002 |
| SLAM versus neutrophils % BALF | 0.44 | 0.009 |
| SLAM versus eosinophils % BALF | –0.13 | ns (p = 0.44) |
| SLAM versus IL-8 BALF | 0.01 | ns (p = 0.92) |
| SLAM versus IL-8 EBC | –0.28 | ns (p = 0.10) |
| SLAM versus FEV1/FVC (%) | –0.03 | ns (p = 0.86) |
| SLAM versus FEV1 (%pred.) | –0.50 | 0.005 |
| SLAM versus FVC (%pred.) | –0.57 | 0.001 |
| SLAM versus TLC (%pred.) | –0.31 | ns (p = 0.15) |
BALF bronchoalveolar lavage fluid, EBC exhaled breath condensate, FEV 1 forced expiratory volume in 1 s, FVC forced vital capacity, ns not significant, SLAM systemic lupus activity measure, TLC total lung capacity, %pred. % predicted